top of page
DietRoute3-01.png

TrueVit LipoPlan is specifically formulated to contribute to the reduction of body weight in conjunction with an energy restricted diet. TrueVit LipoPlan contributes to the reduction of body weight due to the active ingredient Glucomannan. Glucomannan is a water soluble fiber which expands in the stomach in the presence of water to form a gel to promote the feeling of fullness. Glucomannan is clinically proven as a weight loss active ingredient.


The addition of Chromium to the formula helps contribute to the maintenance of normal macronutrient metabolism (fat, protein and carbohydrate metabolism) and the maintenance of normal blood glucose levels.

ICONS FOR DR WEB-28.png
ICONS FOR DR WEB-18.png
GMP logo for product pages (pop up).png
ICONS FOR DR WEB-06.png
ICONS FOR DR WEB-27.png

Product Dosage Info

Glucomannan
Chromium

Av. per 6 capsules

3g

3μg

% EC RDA

-

90

Directions​

Take two capsules half an hour before breakfast, two capsules half an hour before lunch and two capsules half an hour before dinner. Take each serving with 1-2 glasses of water. Do not chew. Do not exceed the recommended daily intake unless otherwise directed by a healthcare professional. Store in a cool, dry place below 25ºC.

Caution

Do not use if you are allergic to any of the ingredients.

Taking this product without adequate fluids may cause choking.

 

Do not take this product if you have difficulty in swallowing.
Take this product with plenty of water to ensure that the substance reaches the stomach.

 

Food Supplements

As with other supplements, seek professional advice before using if you are on medication, pregnant, breast-feeding or suffer from food allergies.

 

Food supplements must not replace a varied, balanced diet and a healthy lifestyle.

 

Pack contains 90 capsules.

Keep out of sight and reach of children.

mg=milligrams

μg=micrograms

IU=International Units

RDA=Recommended Daily Allowance

-=No RDA established.

Join our mailing list for all the latest updates...

Congrats! You’re subscribed

bottom of page